AlzeCure Pharma to present at Redeye Neurology Day
AlzeCure Pharma will attend Redeye Neurology Day in Stockholm on Oct. 15, 2026, where CEO Martin Jönsson will present an update on outlicensing agreements with Eli Lilly and QuantumCell.
AlzeCure Pharma will attend Redeye Neurology Day in Stockholm on Oct. 15, 2026, where CEO Martin Jönsson will present an update on outlicensing agreements with Eli Lilly and QuantumCell.